FDA clears Zephyr's latest update to MATRx plus

By DrBicuspid.com staff writers

November 30, 2020 -- The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to medical device company Zephyr Sleep Technologies' latest update to MATRx plus.

The clearance eliminates the requirement for a nasal cannula during a sleep theranostic test and makes setting up the take-home Treatment Planning test simpler. Patients now only need a single fingertip pulse oximetry probe for the test.

All existing MATRx plus users who are Connected Program subscribers will receive the update at no additional charge.

Copyright © 2020 DrBicuspid.com

To read this and get access to all of the exclusive content on DrBicuspid.com create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a DrBicuspid.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking